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DIFFERENCES OF THE T CELL FUNCTIONAL PROFILE IN 
TWO VACCINE REGIMENS USING FLOW CYTOMETRY 
Kristen Kopf and Nancy Sullivan* 
Biology Department, Illinois Wesleyan University 
The National Institutes of Health 
Ebola hemorrhagic fever is a severe, often fatal disease in humans and nonhuman primates that is 
found primarily in central Africa. With a mortality rate between 50% and 90%, and no known 
cure available, it is necessary to develop a vaccine for protection. 
Previous studies have shown that DNA vaccine only regimen does not provide protection against 
Ebola in Macaques whereas the regimen of DNA vaccine priming with the addition of 
recombinant Adenoviruse (DNAIrAdv) boosting does. Since the antibody titers in the DNA only 
animals are comparable with those in the DNAIrAdv regimen, this suggests it is a T cell, and not 
a B cell, response deficiency that leads to failed protection. Thus, by examining the profiles of T 
cell responses from the same animal before and after rAdv boosting, we can determine the 
threshold between protective and non protective immunity, and provide better insight into vaccine 
design for Ebola virus. 
To carry out these aims, we used multiparameter flow cytometry, looking for an antigen specific 
response. We then used the programs SPICE and FlowJo to analyze the data. Our data reveals a 
higher T-cell response with the DNAIrAdv regimen, although one can see from this study that 
the quality of immune response differs in ways other than the number of T cells generated. 
